Compound Summary
Compound Information
NECA
Compound Name: | NECA |
Compound CID: | 448222 |
Synonyms: | NECA 5-N-Ethylcarboxamidoadenosine 35920-39-9 Adenosine-5-(N-ethylcarboxamide)" 5-Ethylcarboxamido Adenosine More... |
Iupac Name: | (2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide |
InChI: | InChI=1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1 |
InChIKey: | JADDQZYHOWSFJD-FLNNQWSLSA-N |
Canonical Smiles: | CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O |
Isomeric Smiles: | CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O |
Molecular Weight: | 308.29 |
Molecular Formula: | C12H16N6O4 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
NECA
Molecular Weight: | 308.29 |
Molecular Formula: | C12H16N6O4 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 8 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 22 |
Complexity: | 426 |
Synonyms
NECA
| NECA | NECA |
|---|---|
NECA |
5-N-Ethylcarboxamidoadenosine |
35920-39-9 |
Adenosine-5-(N-ethylcarboxamide)" |
5-Ethylcarboxamido Adenosine |
3HNECA |
N-ethyl-5-carboxamidoadenosine |
1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-ethyl-beta-D-ribofuranuronamide |
MLS000069759 |
CHEMBL464859 |
CHEBI:73284 |
MFCD00069195 |
5-N-ETHYLCARBOXAMIDO-ADENOSINE |
SMR000058759 |
b-D-Ribofuranuronamide, 1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl- |
(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide |
(2S,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamide |
NEC |
5-ethylcarboxamidoadenosine |
N-Ethylcarboxamidoadenosine |
Adenosine, N6-Ethyl-carboxamido |
5-n-ethylcarboxamidoadenosine (neca) |
2ydv |
Adenosine analog, 3 |
5-N(Sup 6)-Ethylcarboxamidoadenosine" |
3Hadenosine-5-(N-ethylcarboxamide) |
1qy5 |
Opera_ID_470 |
GTPL377 |
GTPL425 |
5-Ethylcarboxamido-adenosine |
MLS002153347 |
REGID_for_CID_448222 |
SCHEMBL16585523 |
BDBM21220 |
5-(N-Ethylcarboxamido)adenosine |
Adenosine-5-(N-ethylcarboxamide) |
DTXSID801017234 |
HMS2234O07 |
HMS3412B16 |
HMS3676B16 |
ZINC3995401 |
s6347 |
AKOS024456749 |
CS-8131 |
NCGC00025260-02 |
NCGC00025260-03 |
NCGC00025260-04 |
NCGC00025260-05 |
5-(N-Ethylcarboxamido)adenosine, powder |
AC-27392 |
HY-103173 |
Q27087892 |
5 inverted exclamation mark -Ethylcarboxamido Adenosine |
1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-ethyl-?-D-ribofuranuronamide |
beta-D-Ribofuranuronamide, 1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl- |
(2S,3S,4R)-5-(6-Aminopurin-9-yl)-N-ethyl-3,4-dihydroxy-oxolane-2-carboxamide |
(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide |
5-N-Ethylcarboxamidoadenosine; D-NECA; NECAMolecular Formula: C12H16N6O4 |
Ribofuranuronamide, 1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl-, hemihydrate |
(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxytetrahydrofuran-2-carboxamide (non-preferred name) |
100111-00-0 |
Experimental Data
NECA
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -5 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
NECA
Statistics Data
NECA
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -5 | 1 | 1 |
Statistics Data Visualization
NECA
